Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
clinical hold
Pharma
BMS, China reimbursement update, CAR-T hold—Fierce Pharma Asia
BMS signed a massive ADC deal. AZ and Gilead's ADCs passed on China's national insurance scheme. The FDA put three CARsgen CAR-Ts on clinical hold.
Angus Liu
Dec 15, 2023 5:15am
ADC Therapeutics scraps Zynlonta study after FDA partial hold
Jul 21, 2023 11:13am
Astellas, J&J, Sun and more—Fierce Pharma Asia
May 5, 2023 8:55am
'The Top Line': Sarepta's DMD trial, Illumina's Grail quest
Sep 9, 2022 6:00am
FDA slaps clinical hold on Pharvaris' HAE med
Aug 22, 2022 9:58am
Astellas, Fujifilm, Lundbeck-Otsuka—Fierce Pharma Asia
Jul 1, 2022 9:40am
